Indigo monitors tests for registrations of 13 new bioinputs in Brazil

The global research and development (R&D) team of Indigo arrived in Brazil to tour various regions of the country, with the aim of monitoring tests for the registrations of 13 new bioinputs.

Experts from the startup specializing in biological technologies and financial solutions conducted technical visits of cities in the Brazilian regions of the Midwest and Northeast.

The technicians visited renowned research centers in Brazil, which are conducting trials for the registrations of Indigo products, such as MultCrop, Biovalidare, and Staphyt.

During this crop season, Indigo is testing 6 inoculants, 3 bionematicides, and 4 biofungicides, all of which are already undergoing advanced trial stages.

Other visits will be made to research units where commercial trials are being conducted with biotrisinc simplex, an inoculant and bio-stimulant containing growth-promoting microorganisms for corn and soybean crops. It is also the only product based on bacillus simplex in Brazil.

In addition, other research is being carried out with the biological nematicide, N11 FP, which is indicated for seed treatment on all crops with occurrences of biological targets.

According to Reinaldo Bonnecarrere, Director of Biologicals at Indigo, these immersions in local agriculture are key to better understanding the needs of the Brazilian market in terms of the development of new products.

″Brazil is a continental country. Regarding research in the development of techniques for agriculture, everything must be taken into consideration, from climate to soil quality. The information collected will serve as a basis for technologies, to reach the highest standards of satisfaction and success required in the field,″ Bonnecarrere said.

For studies involving research and development, centers located in Brazil differ from other countries due to several factors, which range from climate variations to the most recent agricultural techniques.

″Due to have a younger agricultural sector, there are factors that must be considered, mainly because they only exist in Brazil, so an adapted model is necessary for each region. In addition to factors such as climate, which have not yet stabilized in terms of having proven climate models, as we are limited to models that are 20 years old at most and require more attention regarding their variations,″ said Rodrigo Marcelo Pasqualli, Executive Director of Fundação Rio Verde.

The biological inputs market is in full growth, and Brazil occupies a prominent position, especially when considering the size of the country’s agricultural production and its global importance.

According to market estimates released by Fortune Business Insights, from 2022 to 2029, the sector’s profits are expected to increase by 15.77%, jumping from US$6.51 billion to US$18.15 billion. Following the same growth trajectory are biofertilizers (12.04%), predicted to increase from US$2.02 billion to US$4.47 billion, and biostimulants (11.43%), rising from US$3.14 billion to US$6.69 billion.

″The biologicals market is growing faster than the chemical market. On average, we reach values of 30% to 50% per year, with some segments growing above this level. Biocontrols, bionematicides, and biofungicides are good examples, driven by product results in the field. Today, the bionematicides market accounts for 80% of total nematicides,″ Bonnecarrere added.

This reality allows for the greater involvement of research institutions, as various cultures and techniques have been seen to interact at the same time.

″We are dealing with a lot of knowledge and interaction. Events that occurred in the previous harvest can be overcome, but farmers need information quickly to prepare for the next harvest. This is where research institutions come in, and they need to adapt to this reality and meet the demand for reliable information,″ Pasqualli said in conclusion.

(Editing by Leonardo Gottems, reporter for AgroPages)